The 20 Best Monoclonal Gammopathy of Undetermined Significance (MGUS) Doctors Near Me in New York, US

. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

Malin Hultcrantz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Hultcrantz is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration. Dr. Hultcrantz is currently accepting new patients.

Sham Mailankody is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Mailankody is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mailankody is currently accepting new patients.

Jens Hillengass is an Oncologist practicing medicine in Buffalo, New York. Dr. Hillengass is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

. Dr. Parylo is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC). Dr. Parylo is board certified in American Board Of Internal Medicine.

. Dr. Allerton is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Allerton is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, Medical Oncology, American Board Of Internal Medicine, Hospice And Palliative Medicine, and American Board Of Internal Medicine, Internal Medicine.

Joshua Raff, M.D. is the Director of the Digestive Cancer Program at White Plains Hospital, as well as the Leader of the Hospital's GI Cancer Program Conference. Dr. Raff received his medical degree from the Sackler School of Medicine at Tel Aviv University in 1997. He completed his residency in internal medicine at Montefiore Medical Center in the Bronx, and was a fellow of hematology and oncology at Albert Einstein College of Medicine from 2000-2003. Dr. Raff is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), and Familial Pancreatic Cancer. Dr. Raff is board certified in American Board Of Internal Medicine.

Anna Komorowski is a Hematologist and an Oncologist practicing medicine in Sleepy Hollow, New York. Dr. Komorowski is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), Anemia, Schnitzler Syndrome, and Bone Marrow Aspiration. Dr. Komorowski is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Osteosarcoma, Chondrosarcoma, and Angiosarcoma.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Anna Kurzyna is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Kurzyna is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Hemolytic Crisis, Childhood Iron Deficiency Anemia, Chronic Lymphocytic Leukemia (CLL), and Inflammatory Breast Cancer.

Ronnie Luyun is an Oncologist and an Internal Medicine provider practicing medicine in Albany, New York. He has been practicing medicine for over 30 years. Dr. Luyun is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Paget Disease of the Breast, and Ewing Sarcoma. Dr. Luyun is board certified in American Board Of Internal Medicine Subspecialty, Hematology and American Board Of Internal Medicine Subspecialty, Medical Oncology. Dr. Luyun is currently accepting new patients.

"Dr. Lentzsch is a Professor of Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. She received her medical and doctorate degrees from Humboldt University in Berlin, Germany, where she also completed her residency and fellowship. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr. Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, MA, USA.Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia.Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation ""Black Swan Research Initiative"" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.". Dr. Lentzsch is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. Lentzsch is currently accepting new patients.

Heather Landau is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Landau is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Primary Amyloidosis, Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Cardiac Amyloidosis, and Bone Marrow Transplant. Dr. Landau is currently accepting new patients.

Ruben Niesvizky is an Oncologist practicing medicine in New York, New York. Dr. Niesvizky is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Niesvizky is currently accepting new patients.

Samir Parekh is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Parekh is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant. Dr. Parekh is currently accepting new patients.

Dr. Lederman received her medical degree from Cornell Medical College and completed residency in Internal Medicine at The Mount Sinai Hospital in New York. After serving one year as Chief Resident in Internal Medicine at Elmhurst Hospital in Queens, she completed fellowship training in Hematology and Oncology at New York Medical College/Westchester Medical Center. She served New York Medical College as Assistant Clinical Professor for several years, as well as being an active member of the New York Blood Center Transfusion Service. Dr. Lederman is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses GTP Cyclohydrolase 1 Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, Pseudocholinesterase Deficiency, and Deep Vein Thrombosis. Dr. Lederman is board certified in American Board Of IM/Hematology.

Jeffrey Halaas is a Hematologist and an Oncologist practicing medicine in Mount Kisco, New York. Dr. Halaas is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Pleuropulmonary Blastoma, Thrombocytopenia, and Monoclonal Gammopathy of Undetermined Significance (MGUS). Dr. Halaas is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Dr. Henny Billett has been Chief of the Division of Hematology since 2012 and Professor of Clinical Medicine and Pathology since 2002. Dr. Billett is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Antiphospholipid Syndrome, Mesenteric Venous Thrombosis, Sickle Cell Disease, Venous Thromboembolism (VTE), and Splenectomy.

Julie Gold is a Hematologist and an Oncologist practicing medicine in Mount Kisco, New York. Dr. Gold is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and HER-2 Positive Breast Cancer. Dr. Gold is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.